Navigation Links
Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA
Date:9/3/2013

ancin) shipments into the US wholesaler channel. The Company informed that VIBATIV, discovered and developed by Theravance, is approved in the US for the treatment of adult patients with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP), as well as for the treatment of complicated skin and skin structure infections (cSSSI). "VIBATIV is an important treatment option for physicians and patients dealing with serious MRSA infections," said Rick E. Winningham, CEO of Theravance. "Theravance intends to provide a level of medical support with this product reintroduction to enable physicians to properly use VIBATIV while we continue to evaluate commercialization alternatives in the U.S." The Full Research Report on Theravance, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/fa70_THRX]

XOMA Corporation Research Report

On August 7, 2013, XOMA Corporation (XOMA) reported its Q2 2013 financial results. In Q2 2013, the Company's total revenues were $7.2 million, down 22.9% YoY, which reflected a reduction in license and collaborative fees. The Company reported Q2 2013 net loss of $17.2 million, or $0.21 per share, compared with a net loss of $16.2 million, or $0.24 per share, in Q2 2012. For full-year 2013, XOMA reconfirmed its anticipation that cash worth c.$50 million will be used in the ongoing operating activities during 2013, reflecting the costs associated with conducting clinical and preclinical activities. The Full Research Report on XOMA Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/9a56_XOMA'/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Commercial Biotechnology Separation Systems Market Analyzed in New Research Report at ReportsnReports.com
2. The Zacks Analyst Blog Highlights: SPDR Health Care Select Sector Fund, SPDR S&P 500, SPDRS&P Biotech ETF, PowerShares S&P SmallCap Health Care Portfolio and PowerShares Dynamic Biotechnology & Genome Portfolio
3. Worldwide Marine Biotech Market 2016
4. Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2012-2016 Report Available Online by Researchmoz.us
5. Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme
6. Sanguine BioSciences Announces Distribution Partnership with AMS Biotechnology
7. The BioTechniques 30th Anniversary Lecture Announced as Part of the 2013 BioTechniques Virtual Symposium
8. Midwest Biotech Leaders Featured On BioSpace Map
9. Biotech & BioPharma Professionals: CA Board of Pharmacy Executive, Virginia Herold, to Deliver Keynote at BSMA Annual Biotechnology Conference Oct 8-9
10. Biotech Industry Veteran Joseph Bolen Joins Moderna Therapeutics to be President of Research and Development
11. Biotechnology (BSMA) Conference For Supply Chain Professionals Returns To Foster City, October 8-9, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Massachusetts, USA (PRWEB) November 26, 2014 ... more accuracy, additive systems to enable 3D manufacture at ... analyzing road conditions are among finalists in nine categories ... . The awards are sponsored by SPIE, the ... Photonics Media . , Winners will be announced by ...
(Date:11/26/2014)... In keeping with the holiday spirit, DNA ... Thanksgiving savings. The company is offering up a variety ... this holiday weekend as well as a photo contest ... Monday are right around the corner, and DNA Spectrum ... and those looking to explore their ancestry, health, and ...
(Date:11/26/2014)... 2014 The ETC (Emerging Technology ... innovation centers, announced today that applications for AccelerateBaltimore™ ... 1st. “Do you have a big idea?,” asked ... to know about it. AccelerateBaltimore helps you and ... in just 13 weeks.” Interested game changers ...
(Date:11/26/2014)... 2014 Continuing its award-winning streak, Nerium ... prestigious MarCom Awards for outstanding creative achievement by its ... MarCom Award, the organization’s top honor, in the Branding ... held in April of this year. The event showcased ... Additionally, Nerium was awarded a Gold MarCom Award in ...
Breaking Biology Technology:Finalists Named for 2015 Prism Awards for Photonics Innovation 2Finalists Named for 2015 Prism Awards for Photonics Innovation 3Finalists Named for 2015 Prism Awards for Photonics Innovation 4Finalists Named for 2015 Prism Awards for Photonics Innovation 5DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3AccelerateBaltimore Applications to Close in 6 Days 2AccelerateBaltimore Applications to Close in 6 Days 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2
... FRANCISCO, March 11 VIA Pharmaceuticals,(Nasdaq: VIAP ... of,compounds for the treatment of cardiovascular disease, announced ... James G. Stewart, senior,vice president and chief financial ... Cowen and Company 28th Annual Health Care Conference ...
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ), a clinical-stage ... of,novel small-molecule therapeutics, today reported financial results for ... Total revenue for the fourth quarter of ... $8.8 million. Total revenue for the year ended ...
... N.J., March 11 Pharmacopeia,(Nasdaq: PCOP ), an ... therapeutics, today announced that Dr. Leslie J. Browne,President and ... Cowen and Company 28th Annual Health Care Conference.,The conference ... The Boston Marriott,Copley Place, Boston, Massachusetts., Dr. Browne,s ...
Cached Biology Technology:Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 2Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 3Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 4Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 5Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 6Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 7Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 8Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 9Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results 10Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference 2Pharmacopeia to Present at the Cowen and Company 28th Annual Health Care Conference 3
(Date:11/3/2014)... from Australia report that low birth weight and preterm ... hip replacements in adulthood. Findings published in the American ... Research , indicate that low birth weight and pre-term ... due to OA as adults. , According to ... 25 are diagnosed with clinical OA. Symptoms of OA ...
(Date:11/2/2014)... (2 November 2014)—In support of a bold quest to ... Melinda Gates Foundation today announced an award of US$156 ... Initiative (MVI) in building new vaccines that will interrupt ... the "accelerating to zero" agenda. Such vaccines would ensure ... be called an "immunological bed net." , This ...
(Date:11/2/2014)... a bar and bump into a biologist . . . ... late-night nerd sketch, researchers have taken this premise and applied ... finding meaning in the rising oceans of genomic data. , ... that genome-wide studies are publishing at a dizzying rate. The ... signal from the noise (and there is no shortage of ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Mutant models 2Mutant models 3Mutant models 4
... patients miserable and debilitated with chronic itching or pain ... possible paralysis or damage to the brain and other ... effective treatment even though the responsible gene was identified ... done to treat a disease that affects more people ...
... have identified a specific protein molecule that is used ... leading the way for development of future vaccines to ... issue of Science Express, the study provides insight into ... problem of great scientific and clinical importance. , Most ...
... field trials in China report higher crop yields, reduced ... a study by researchers in China and at Rutgers ... of the study will appear in the April 29 ... two of the four GM varieties that are now ...
Cached Biology News:Potential treatments for neurofibromatosis 2Potential treatments for neurofibromatosis 3Yale researchers identify molecule for detecting parasitic infection in humans 2Genetically modified rice in China benefits farmers' health, study finds 2Genetically modified rice in China benefits farmers' health, study finds 3Genetically modified rice in China benefits farmers' health, study finds 4